• LAST PRICE
    11.0100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    10.5500/ 1
  • Ask / Lots
    11.2500/ 1
  • Open / Previous Close
    9.9700 / 11.0100
  • Day Range
    Low 9.9100
    High 11.3400
  • 52 Week Range
    Low 3.7800
    High 14.9600
  • Volume
    142,622
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 9.97
TimeVolumePLSE
09:32 ET30809.97
09:34 ET1009.97
09:38 ET1529.91
09:39 ET21169.97
09:45 ET10010.045
09:50 ET110010.035
09:52 ET45010.2
09:54 ET10010.28
10:01 ET20510.205
10:03 ET53610.24
10:06 ET1030510.34
10:08 ET10010.34
10:12 ET70010.41
10:15 ET20010.43
10:17 ET231610.52
10:19 ET270010.6383
10:21 ET328510.64
10:26 ET70010.74
10:30 ET20010.7
10:32 ET194410.75
10:33 ET30010.7427
10:35 ET10010.8
10:39 ET80010.8979
10:42 ET25010.82
10:44 ET200810.95
10:46 ET50010.99
10:51 ET165510.895
10:53 ET65010.93
10:55 ET50010.97
10:57 ET10011.04
11:00 ET50010.96
11:02 ET40011.06
11:04 ET191211.05
11:06 ET21511.08
11:09 ET10011.045
11:11 ET10011.04
11:15 ET83611.1
11:18 ET91811
11:20 ET30011.06
11:22 ET27711.045
11:24 ET10011.13
11:27 ET10011.08
11:29 ET505810.975
11:40 ET494210.79
11:49 ET40010.94
11:51 ET69010.915
11:54 ET10010.97
12:00 ET145811.05
12:02 ET90011.07
12:03 ET10011.08
12:05 ET40011.08
12:07 ET10011.12
12:12 ET10011.05
12:14 ET10011.11
12:16 ET63311.1
12:18 ET10011.13
12:23 ET30011.13
12:27 ET170011.11
12:30 ET10011.115
12:32 ET10011.105
12:34 ET92811.205
12:36 ET53811.25
12:38 ET50011.3
12:39 ET344411.23
12:41 ET10011.185
12:43 ET10011.155
12:50 ET75011.11
12:56 ET97311.11
12:57 ET20011.08
12:59 ET344110.94
01:01 ET50010.945
01:03 ET20010.9555
01:08 ET17110.955
01:10 ET10010.955
01:14 ET10010.96
01:17 ET10011
01:19 ET25210.97
01:24 ET20010.97
01:28 ET180010.8106
01:30 ET91110.75
01:32 ET120010.7901
01:39 ET10010.795
01:42 ET15210.79
01:44 ET130010.83
01:46 ET20010.88
01:51 ET37810.825
01:55 ET25310.825
01:57 ET20010.87
02:02 ET101910.78
02:04 ET10010.8
02:08 ET62110.79
02:11 ET10010.785
02:15 ET29510.81
02:18 ET10010.87
02:20 ET60010.86
02:22 ET17210.815
02:27 ET10010.86
02:31 ET10010.87
02:36 ET25210.825
02:40 ET10010.87
02:45 ET20010.835
02:49 ET10010.89
02:51 ET74010.99
02:54 ET10010.97
02:58 ET20010.925
03:00 ET20010.935
03:02 ET10010.94
03:05 ET20010.95
03:07 ET10010.95
03:09 ET15210.95
03:12 ET10010.9999
03:14 ET29011.06
03:16 ET57910.975
03:20 ET10010.96
03:25 ET55211.0599
03:27 ET10011.06
03:30 ET220010.97
03:34 ET41910.92
03:38 ET35810.92
03:39 ET10010.93
03:41 ET20010.95
03:43 ET39410.95
03:45 ET10010.96
03:48 ET119910.9
03:50 ET10010.86
03:54 ET184910.87
03:56 ET154010.94
03:57 ET184210.98
03:59 ET273811.01
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPLSE
Pulse Biosciences Inc
550.6M
-13.5x
---
United StatesNNOX
Nano-X Imaging Ltd
381.4M
-6.2x
---
United StatesOBIO
Orchestra Biomed Holdings Inc
245.5M
-5.4x
---
United StatesCBUS
Cibus Inc
230.6M
-0.5x
---
United StatesMXCT
MaxCyte Inc
427.6M
-11.3x
---
United StatesEUDA
EUDA Health Holdings Ltd
133.1M
-11.3x
---
As of 2024-06-28

Company Information

Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.

Contact Information

Headquarters
3957 Point Eden WayHAYWARD, CA, United States 94545-3720
Phone
510-906-4600
Fax
302-655-5049

Executives

Executive Chairman of the Board
Robert Duggan
President, Chief Executive Officer, Director
Burke Barrett
Chief Technology Officer, Director
Darrin Uecker
Chief Commercial Officer
Kevin Danahy
Chief Strategy Officer
Mitchell Levinson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$550.6M
Revenue (TTM)
$0.00
Shares Outstanding
55.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.74
EPS
$-0.82
Book Value
$0.80
P/E Ratio
-13.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.